ArticleEuropean heart journal. Case reports2026
A multicomponent cardiac rehabilitation programme as a safe, feasible, and beneficial approach, including patients with left ventricular assist devices: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left ventricular assist devices (LVADs) are a well-established therapy for advanced heart failure (HF) used either as a bridge-to-transplant or destination therapy. While cardiac rehabilitation programmes (CRPs) are guideline-recommended in other HF stages, specific data on their role in LVAD recipients remains limited. We present a case of tailored CRP in a LVAD-supported patient highlighting the importance of understanding the device's intrinsic limitations to ensure safe and effective exercise prescription. Case summary: A 56-year-old man with cardiovascular risk factors presented with anterior ST-elevation myocardial infarction developing severe left ventricular dysfunction, INTERMACS III, and recurrent ventricular arrhythmias, leading to HeartMate 3 (HM3) LVAD implantation as a bridge-to-transplant. Persistent smoking led to discontinuation of prehabilitation and removal from the transplant waitlist. A destination therapy strategy was considered and referred to the CRP. Baseline and final assessments included a CPET-ESE, clinical-functional evaluation, and PROMs. The rehabilitation physician, as part of the multidisciplinary team, adapted the exercise prescription to manage neuropathic pain due to a suspected spinal cord injury. Doppler-MAP and HM3 LVAD parameters were monitored before and after each session. The patient completed a tailored 12-week CRP with high adherence and no major adverse events. Improvements were observed in submaximal CPET parameters: VO₂ at VT1, OUES and VE/VCO₂ slope, right ventricle contractility, muscular efficiency, and QoL. Persistent smoking remained the main management challenge. Discussion: Tailored CRP with careful haemodynamic monitoring is safe, feasible, and effective in patients with HM3 LVAD. A multidisciplinary approach is essential to optimize functional outcomes and long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.